中文

U.S. Stocks · Health Care · Free Data Page

UNITED THERAPEUTICS Corp UTHR

UNITED THERAPEUTICS Corp: FY2025 revenue $3.18B (+10.60% YoY); net income $1.33B; all 17 risk checks passed with 0 alerts.
Close Price$582.46Day +3.64%Market Cap$24.81BP/E18.6xFY2025 earningsP/B3.50xROE (FY2025)19.7%Avg. equity

Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for UNITED THERAPEUTICS Corp?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2016–2025

Key Multi-Year Facts

  • Revenue moved from $1.60B in FY2016 to $3.18B in FY2025 (9-year CAGR +7.9%).
  • Net income was negative in FY2019.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)1.691.942.332.883.18
YoY13.6%14.9%20.2%23.6%10.6%
Net Income (USD B)0.480.730.981.201.33
YoY-7.6%52.9%35.4%21.4%11.7%
Operating Cash Flow (USD B)0.600.800.981.331.56
ROE12.9%16.6%18.3%19.2%19.7%
Gross Margin92.7%92.2%88.9%89.2%87.9%
Net Margin28.2%37.6%42.3%41.5%41.9%
Debt-to-Assets23.4%20.6%16.5%12.5%9.9%
Show all 10 fiscal years
Fiscal Year2016201720182019202020212022202320242025
Revenue (USD B)1.601.731.631.451.481.691.942.332.883.18
YoY—7.9%-5.7%-11.0%2.4%13.6%14.9%20.2%23.6%10.6%
Net Income (USD B)0.710.420.59-0.100.510.480.730.981.201.33
YoY—-41.4%41.0%-117.7%—-7.6%52.9%35.4%21.4%11.7%
Operating Cash Flow (USD B)0.640.470.78-0.210.760.600.800.981.331.56
ROE38.6%21.1%24.1%-3.8%16.7%12.9%16.6%18.3%19.2%19.7%
Gross Margin95.5%93.9%87.8%91.9%92.7%92.7%92.2%88.9%89.2%87.9%
Net Margin44.6%24.2%36.2%-7.2%34.7%28.2%37.6%42.3%41.5%41.9%
Debt-to-Assets19.9%26.3%17.4%29.0%26.4%23.4%20.6%16.5%12.5%9.9%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-10

Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).

0Alert 0Watch 15Pass 2N/A

Checked across financial quality, solvency, going concern, and SEC material filings (bankruptcy, delisting notice, auditor change, non-reliance, late filing) with no alerts or watch items triggered.

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?

Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.